Sexually Transmitted Diseases

Researchers have found incidence of multidrug-resistant HIV-1 infection, despite the use of preexposure prophylaxis (PrEP).

Researchers from the University of Pennsylvania Perelman School of Medicine show that many young transgender women are aware of HIV PrEP and have positive attitudes toward it.

Johns Hopkins University researchers conducted a survey with the goal of finding out the prevalence of HIV testing among nonclinical community-based organizations in Baltimore, Maryland.

Catch up on last month's top infectious disease news coverage from Contagion®.

Higher rates of self-reported drug use exist among the HIV-positive population, highlighting the need for interventions in at-risk populations.

Researchers at the Weizmann Institute of Science have discovered that phages are able to communicate with each other in order to coordinate how to best approach the infection process.

Researchers at Rockefeller University in New York have discovered that a potent monoclonal antibody known as 10-1074 is highly effective at neutralizing various HIV strains.

Cancer specialists at the UT Southwestern Medical Center are reminding women to continue going for Pap smears even if they have received the human papillomavirus (HPV) vaccine.

Researchers have developed a new trivalent vaccine that has proven to provide powerful protection against genital herpes (HSV) in preclinical trials.

New Hampshire is currently experiencing a serious gonorrhea outbreak that may be difficult to contain for a number of reasons.

Researchers from the University of Pennsylvania identify characteristics of HIV-1 strains that are able to get through innate protective barriers and cause infection through sexual intercourse.

Researchers from Penn State College of Medicine have developed a Retro94-based compound that may be able to prevent cytomegalovirus (CMV) from copying itself.

A new study has revealed an alarmingly high rate of HPV infections in men in the United States.

UCLA researchers have developed an online risk assessment calculator that will allow individuals to check their “PrEP score.”

Drug “buyers clubs” that include websites such as PrEPster and I Want PrEP Now are providing a number of at-risk individuals living in the United Kingdom with HIV drugs that can potentially save their lives.

Researchers offer more insight on the role of IFN-I and find a potential therapeutic target that may be able to protect against chronic viral infections.

Diverse vaginal bacteria that’s deficient in lactobacilli appears to raise the risk of contracting HIV.

In a recent study, researchers found that retroviruses, such as HIV, date back to the Paleozoic Era.

In response to the increasing number of syphilis cases reported in Japan, the Japanese government is launching a prevention campaign that will include Sailor Moon as a spokesperson for sexual education.

A new genital herpes drug, pritelivir, has demonstrated greater virus suppression than the present standard treatment in a clinical trial.

Oluwatoyin (Toyin) Adeyemi, MD, attending physician of infectious diseases at Cook County Health and Hospital System, discusses the Centers for Disease Control and Prevention’s (CDC) sexually transmitted disease (STD) testing guidelines.

As adults are living longer, they are able to continue to have healthy sex lives. Unfortunately, many are not practicing safe sex, and healthcare practitioners are not screening their older patients for sexually transmitted diseases (STDs).

Seeking to improve the nation’s health and safety, the Centers for Disease Control and Prevention (CDC) has been targeting several high-burden issues in which it could make the greatest impact, and three such issues are infectious diseases.

A team from Duke University’s Developing World Healthcare Technologies Lab have discovered a way to extend the lifespan of antiretroviral drugs in order to prevent mother-to-child HIV transmission in developing countries.

With cases of antibiotic-resistant gonorrhea on the rise, researchers from the University of York may have made a breakthrough in the quest to find treatments that work.